Systemic Juvenile Idiopathic Arthritis (sJIA)

Overview


Plain-Language Overview

Systemic Juvenile Idiopathic Arthritis (sJIA) is a type of arthritis that affects children and involves inflammation throughout the whole body. It primarily impacts the joints, causing pain, swelling, and stiffness, but also causes symptoms like fever, rash, and fatigue. This condition affects the immune system, which mistakenly attacks the body's own tissues. The inflammation can lead to difficulty moving and performing daily activities. Because it involves multiple body systems, it can sometimes cause serious complications affecting the heart, liver, or lungs.

Clinical Definition

Systemic Juvenile Idiopathic Arthritis (sJIA) is a subtype of juvenile idiopathic arthritis characterized by systemic inflammation and arthritis in children under 16 years old. It involves an autoinflammatory process driven by dysregulated innate immunity, with elevated cytokines such as IL-1, IL-6, and IL-18 playing a central role. Clinically, sJIA presents with quotidian fever spikes, an evanescent salmon-pink rash, and arthritis affecting multiple joints. The disease can cause hepatosplenomegaly, lymphadenopathy, and serositis. It is distinguished from other JIA subtypes by its systemic features and risk of life-threatening complications like macrophage activation syndrome (MAS). Diagnosis requires exclusion of infections, malignancies, and other rheumatologic diseases.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.